Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 May 2019 | Story Ruan Bruwer | Photo Zimbio
Simoné Gouws
Simoné Gouws (right) in action for the Protea hockey team last year. The defender will be a key player for the Kovsie team in the Varsity hockey competition.

The coach of the first women’s hockey team of the University of the Free State is confident that they can do well in the upcoming Varsity hockey tournament.

The competition works on a gender-rotation system every year. This will be the fourth term of Varsity hockey for women. The Kovsie women has a good record. In 2013 they ended fourth, in 2015 they were second, and in 2017 fifth.

The Kovsies will be facing the University of Johannesburg (UJ) on Friday 3 May 2019. On Saturday, the Maties is lying in wait and the North-West University on Sunday.

“I am confident that we will be doing well. If each player plays her role very well, we should reach the semi-final stage. We have put in the hard work, with good progress. We have played three matches so far in 2019 and haven’t been on the losing side yet,” said Luke Makeleni, head coach.

In friendlies last month, the Kovsies drew to NWU (0-0), defeated UJ by 3-1, and had a good win (6-0) against the Johannesburg club, Shumbas.

“We have quite an experienced squad, with seven survivors from the previous Varsity hockey competition (in 2017), so they know what is expected,” Makeleni said. He is in his third year of coaching the women.

The Kovsies have several players with national experience. Simoné Gouws made her debut for the Proteas last year. Casey-Jean Botha, Shindré-Lee Simmons, Antonet Louw, and Lizanne Jacobs have all represented the South African U21 team. Botha is also in the Protea squad. 

■ The Kovsie team: Wiané Grobler, Chane Hartel, Mikayla Claassen, Anke Badenhorst, Casey-Jean Botha, Shindré-Lee Simmons, Esté van Schalkwyk, Nadia van Staden, Antonet Louw, Michelle Ngoetjane, Heraldine Olin, Lizanne Jacobs, Refilwe Ralikontsane, Mielanka van Schalkwyk, Nela Mbedu, Simoné Gouws, Frances Louw, Kia-Leigh Erasmus.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept